Repository logo
Communities & Collections
All of DSpace
  • English
  • العربية
  • বাংলা
  • Català
  • Čeština
  • Deutsch
  • Ελληνικά
  • Español
  • Suomi
  • Français
  • Gàidhlig
  • हिंदी
  • Magyar
  • Italiano
  • Қазақ
  • Latviešu
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Srpski (lat)
  • Српски
  • Svenska
  • Türkçe
  • Yкраї́нська
  • Tiếng Việt
Log In
New user? Click here to register. Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Orellana Morocho, Gabriela Lisseth"

Filter results by typing the first few letters
Now showing 1 - 2 of 2
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Item
    Afección de órgano blanco en preeclampsia – eclampsia en pacientes gestantes del Hospital Vicente Corral Moscoso. Periodo enero – diciembre 2017. Cuenca - 2018
    (2019-05-17) Orellana Morocho, Gabriela Lisseth; Tacuri Porras, Karen Daniela; Mejía Chicaiza, Jorge Victoriano
    INTRODUCTION: arterial hypertension (AHT) is the most frequent medical complication during pregnancy; they cover a wide spectrum of conditions, preeclampsia and eclampsia being the first causes of maternal death in our country from 2006 to 2014; producing multiple organ dysfunction that includes cardiovascular, renal, hepatic, hematological and neurovascular alterations. OBJECTIVE: to determine the frequency of white organ involvement due to preeclampsia and eclampsia, at the Hospital Vicente Corral Moscoso. 2017. METHODOLOGY: this is a descriptive and retrospective study that collects the information of 195 patients diagnosed with preeclampsia and eclampsia at the Hospital Vicente Corral Moscoso in 2017; using a previously prepared form and the data analysis was performed in the SPSS v19 program. The data is presented in simple and crossed tables with their respective graphs. RESULTS: Of a total of 6356 patients, 189 presented preeclampsia and 6 eclampsia. 46%, of the population was between 20 and 29 years old. Of the patients with preeclampsia, 67.2% were considered without signs of severity and 32.8% with signs of severity; It was also found that 69.8% had a positive proteinuria / creatinuria index and 84.1% had uric acid with values higher than 4.5 mg/dL; proteinuria being greater in patients with eclampsia. CONCLUSION: laboratory tests have determined that the main organ affected by preeclampsia and eclampsia are the kidneys; which entails a high risk of long-term morbidity and mortality in these patients.
  • Loading...
    Thumbnail Image
    Item
    Afección de órgano blanco en preeclampsia – eclampsia. Hospital Vicente Corral Moscoso, Cuenca
    (2022) Tacuri Porras, Karen Daniela
    Introduction: preeclampsia and eclampsia are frequent complications during pregnancy or the puerperium. They are part of the hypertensive disorders that constitute the main cause of maternal death in Ecuador and the one of the first worldwide. Its timely diagnosis and treatment allows to avoid complications at the level of the target organs. Objective: to determine the frequency of affectation of the target organs by preeclampsia and eclampsia, at the Vicente Corral Moscoso Hospital, year 2017. Methodology: It is a descriptive study, which compiles information from 195 patients diagnosed with preeclampsia and eclampsia at the Vicente Corral Moscoso Hospital in 2017; using a previously prepared form. The data analysis was performed in the SPSSv19 program, determining the relative and absolute frequencies, of the nominal and ordinal qualitative variables. The data is presented in simple and cross tables. Results: from a total of 6356 patients, 189 presented preeclampsia and 6 eclampsia. Of the patients with preeclampsia, 32.8% show signs of severity; 69.8% have a positive proteinuria/creatinuria index and 84.1% have uric acid values greater than 4.5 mg/dl. In patients with eclampsia, the main alteration is proteinuria.Conclusion: the main target organ affected in preeclampsia-eclampsia is the kidney, followed by the liver.

DSpace software copyright © 2002-2025 LYRASIS

  • Privacy policy
  • End User Agreement
  • Send Feedback